Results 281 to 290 of about 418,298 (339)

Telerehabilitation as an innovative strategy for the management of anxiety and dyspnea in post‐COVID‐19: A scoping review

PM&R, EarlyView.
Abstract The COVID‐19 pandemic brought challenges for everyone, especially for patients with persistent sequelae, driving interest in telerehabilitation as an alternative treatment. Additional evidence may be useful to better assess its efficacy and applicability in managing post‐COVID‐19 symptoms.
Gustavo Elias Ferreira Neto, Guilherme Diniz Prudente, Henrique Lima de Oliveira, Khissya Beatryz Alves de Lima, Antônio da Silva Menezes Junior   +4 more
wiley   +1 more source

Plasma cell targeting with the anti-CD38 antibody daratumumab in myalgic encephalomyelitis/chronic fatigue syndrome-a clinical pilot study. [PDF]

Front Med (Lausanne)
Fluge Ø, Rekeland IG, Sørland K, Alme K, Risa K, Bruland O, Tronstad KJ, Mella O.   +7 more
europepmc   +1 more source

Identifying potential biomarkers in the hippocampus of chronic fatigue syndrome rats treated with moxibustion at Zusanli (ST36): a proteomics study. [PDF]

J Tradit Chin Med
Chuwen F, Chaoran LI, Yan Y, Yuanyuan QU, Zhongren S, Weibo S, Tingting L, Shulin LI, Tiansong Y.   +8 more
europepmc   +1 more source

How is wakeful rest operationalized and measured in daily life among adults with and without long‐term conditions? A systematic scoping review

PM&R, EarlyView.
Abstract A systematic scoping review was conducted to examine how rest is operationalized and measured in daily life among adults with and without long‐term conditions. Searches were performed in PubMed, Cumulative Index to Nursing and Allied Health Literature, and Psych databases for studies from 1990 to 2024.
Martin Ackah, Katie L. Hackett, Vincent Deary, Florentina Johanna Hettinga, Hosea Boakye, Ulric Sena Abonie   +5 more
wiley   +1 more source

Association between chronic fatigue syndrome/myalgic encephalomyelitis and cardiovascular disease. [PDF]

Sci Rep
Denu MKI, Revoori R, Eghan C, Kwapong FL, Hillman A, Normeshie CA, Berko KP, Aidoo EL, Buadu MAE.   +8 more
europepmc   +1 more source

Considerations of race and ethnicity within rehabilitation studies for post COVID‐19 condition: A scoping review

PM&R, EarlyView.
Abstract Post COVID‐19 condition (PCC) or long COVID disproportionately affects racial and ethnic minority communities. There are a growing number of rehabilitation studies for PCC, however, it has yet to be determined whether existing studies take race and ethnicity into account in their study designs and whether existing rehabilitative approaches are
Nadine Akbar, Siona Phadke, Sumaya Mehelay, Abdul Kareem Pullattayil, Afolasade Fakolade, Monica Busse   +5 more
wiley   +1 more source

Beneficial effects of intermittent intravenous saline infusion in dysautonomic patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: a case-series. [PDF]

Front Neurol
Sjögren P, Huhmar H, Bertilson BC, Bragée B, Polo O.   +4 more
europepmc   +1 more source

Semi‐mechanistic population PK/PD model to aid clinical understanding of myelodysplastic syndromes following treatment with Venetoclax and Azacitidine

CPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 3, Page 448-459, March 2025.
Abstract Myelodysplastic syndromes (MDS) represent a group of bone marrow disorders involving cytopenias, hypercellular bone marrow, and dysplastic hematopoietic progenitors. MDS remains a challenge to treat due to the complex interplay between disease‐induced and treatment‐related cytopenias.
Neha Thakre, Corinna Maier, Jiuhong Zha, Benjamin Engelhardt, Johannes E. Wolff, Sven Mensing   +5 more
wiley   +1 more source

Defining a High-Quality Myalgic Encephalomyelitis/Chronic Fatigue Syndrome cohort in UK Biobank. [PDF]

NIHR Open Res
Samms GL, Ponting CP.
europepmc   +1 more source